
Fierce Pharma Biopharma News & Insights
4 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
JPM26, Day 1: BMS CEO touts portfolio of blockbuster hopefuls
Jan 12, 2026 · After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco for the industry's big | After a flurry of Big Pharma deals in the ...
Pharma | Fierce Pharma
2 days ago · Generics leader Amneal has bought out Kashiv BioSciences for $1.1 billion in an effort to take advantage of the booming biosimilars market.
2025 approvals: Biopharma delivered 55 new drugs, biologics
Jan 5, 2026 · In 2025, the FDA gave a thumbs-up to 55 new treatments and vaccines, which was down from 60-plus new drugs in 2023.
Trump's pharmaceutical tariffs materialize at last in new US-EU trade ...
Jul 29, 2025 · At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union.
Trump admin rolls out EU trade deal with 15% pharma tariff rate
Aug 21, 2025 · UPDATED: Trump locks in 15% pharmaceutical tariff rate for EU, while generic drugs get a pass
Top 20 pharma companies by 2024 revenue
Apr 21, 2025 · With only one of the biopharma industry’s top 20 revenue companies seeing a year-over-year decline in sales, 2024 was a remarkable year of revenue growth for the industry. Compare that …
Pharmaceuticals tariff to come 'in next month or two': Lutnick
Apr 14, 2025 · U.S. tariffs on pharmaceuticals and semiconductors will come “in the next month or two,” Lutnick said Sunday during an interview on ABC News ’ “This Week.”
Amid industry's onshoring push, Regeneron taps Fujifilm Diosynth for ...
Apr 22, 2025 · Amid industry's onshoring push, Regeneron taps Fujifilm Diosynth for $3B, 10-year commercial manufacturing team-up
Trump administration launches pharma tariff investigation
Apr 15, 2025 · An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump administration disclosed Monday.